However, U251 cells did not exhibit any response to endogenous SVIP depletion (Figures 3B and 3C), whereas breast cancer cell line SKBR-3 (p53 mutant) did not show altered viability (Figure 3C). This evidence concerns the gene TP53 and breast carcinoma.